Home › Antiphospholipid Syndrome › NCT00616317

Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

Who can join

1 Minute – 18 Years · All sexes

Inclusion Criteria:

* 18 years of age or younger at the onset of disease
* Presence of Vascular Thrombosis
* UC Davis patient
* Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma

Exclusion Criteria:

* Infants born to mothers with APS
* Infants with congenital thrombophilia

About the study

The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.

Sponsor: University of California, Davis · Participants: 50 · Started: 2006-09

Contact the study team

• Lavjay Butani · Phone: (916) 734-8118

Official record on ClinicalTrials.gov — NCT00616317

Locations in the U.S.

Conditions

• Antiphospholipid Syndrome

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.